Fluorine in PDB 6xrm: Crystal Structure of Human PI3K-Gamma in Complex with Compound 4
Enzymatic activity of Crystal Structure of Human PI3K-Gamma in Complex with Compound 4
All present enzymatic activity of Crystal Structure of Human PI3K-Gamma in Complex with Compound 4:
2.7.1.153;
2.7.11.1;
Protein crystallography data
The structure of Crystal Structure of Human PI3K-Gamma in Complex with Compound 4, PDB code: 6xrm
was solved by
N.P.Walker,
J.L.Jeffrey,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
106.25 /
2.88
|
Space group
|
C 1 2 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
144.711,
68.649,
106.718,
90.00,
95.38,
90.00
|
R / Rfree (%)
|
24.1 /
30.5
|
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Crystal Structure of Human PI3K-Gamma in Complex with Compound 4
(pdb code 6xrm). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 3 binding sites of Fluorine where determined in the
Crystal Structure of Human PI3K-Gamma in Complex with Compound 4, PDB code: 6xrm:
Jump to Fluorine binding site number:
1;
2;
3;
Fluorine binding site 1 out
of 3 in 6xrm
Go back to
Fluorine Binding Sites List in 6xrm
Fluorine binding site 1 out
of 3 in the Crystal Structure of Human PI3K-Gamma in Complex with Compound 4
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Crystal Structure of Human PI3K-Gamma in Complex with Compound 4 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1101
b:73.1
occ:1.00
|
F1
|
A:V811101
|
0.0
|
73.1
|
1.0
|
C2
|
A:V811101
|
1.4
|
70.7
|
1.0
|
F3
|
A:V811101
|
2.3
|
71.9
|
1.0
|
F4
|
A:V811101
|
2.3
|
76.1
|
1.0
|
C5
|
A:V811101
|
2.4
|
68.6
|
1.0
|
C20
|
A:V811101
|
3.1
|
66.6
|
1.0
|
O19
|
A:V811101
|
3.2
|
68.2
|
1.0
|
C6
|
A:V811101
|
3.4
|
70.4
|
1.0
|
C18
|
A:V811101
|
3.5
|
68.2
|
1.0
|
H2
|
A:V811101
|
3.5
|
70.4
|
1.0
|
HZ1
|
A:LYS833
|
3.6
|
0.1
|
1.0
|
HD11
|
A:ILE963
|
3.6
|
0.5
|
1.0
|
O
|
A:ILE963
|
4.0
|
99.8
|
1.0
|
HG3
|
A:PRO810
|
4.1
|
0.0
|
1.0
|
HB
|
A:ILE963
|
4.1
|
0.7
|
1.0
|
C9
|
A:V811101
|
4.4
|
65.8
|
1.0
|
HD2
|
A:LYS833
|
4.4
|
0.8
|
1.0
|
NZ
|
A:LYS833
|
4.5
|
0.9
|
1.0
|
CD1
|
A:ILE963
|
4.6
|
0.8
|
1.0
|
HG13
|
A:ILE963
|
4.6
|
0.0
|
1.0
|
C7
|
A:V811101
|
4.6
|
70.6
|
1.0
|
HE3
|
A:LYS833
|
4.7
|
0.5
|
1.0
|
N11
|
A:V811101
|
4.8
|
67.6
|
1.0
|
HZ2
|
A:LYS833
|
4.8
|
0.8
|
1.0
|
HD22
|
A:ASN951
|
4.8
|
0.5
|
1.0
|
CG1
|
A:ILE963
|
4.9
|
0.3
|
1.0
|
CB
|
A:ILE963
|
4.9
|
0.8
|
1.0
|
HD12
|
A:ILE963
|
4.9
|
0.1
|
1.0
|
HB2
|
A:ASP964
|
5.0
|
0.4
|
1.0
|
C8
|
A:V811101
|
5.0
|
67.3
|
1.0
|
|
Fluorine binding site 2 out
of 3 in 6xrm
Go back to
Fluorine Binding Sites List in 6xrm
Fluorine binding site 2 out
of 3 in the Crystal Structure of Human PI3K-Gamma in Complex with Compound 4
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Crystal Structure of Human PI3K-Gamma in Complex with Compound 4 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1101
b:71.9
occ:1.00
|
F3
|
A:V811101
|
0.0
|
71.9
|
1.0
|
C2
|
A:V811101
|
1.4
|
70.7
|
1.0
|
F4
|
A:V811101
|
2.2
|
76.1
|
1.0
|
F1
|
A:V811101
|
2.3
|
73.1
|
1.0
|
C5
|
A:V811101
|
2.4
|
68.6
|
1.0
|
HD2
|
A:LYS833
|
2.4
|
0.8
|
1.0
|
O19
|
A:V811101
|
2.8
|
68.2
|
1.0
|
C20
|
A:V811101
|
2.9
|
66.6
|
1.0
|
HZ1
|
A:LYS833
|
3.1
|
0.1
|
1.0
|
C18
|
A:V811101
|
3.2
|
68.2
|
1.0
|
CD
|
A:LYS833
|
3.3
|
0.7
|
1.0
|
HG3
|
A:PRO810
|
3.4
|
0.0
|
1.0
|
HE3
|
A:LYS833
|
3.5
|
0.5
|
1.0
|
C6
|
A:V811101
|
3.5
|
70.4
|
1.0
|
HB2
|
A:LYS833
|
3.6
|
0.9
|
1.0
|
CE
|
A:LYS833
|
3.7
|
0.6
|
1.0
|
HD11
|
A:ILE879
|
3.8
|
99.6
|
1.0
|
H2
|
A:V811101
|
3.8
|
70.4
|
1.0
|
NZ
|
A:LYS833
|
3.8
|
0.9
|
1.0
|
HB3
|
A:PRO810
|
3.9
|
0.1
|
1.0
|
HD13
|
A:ILE879
|
3.9
|
96.8
|
1.0
|
HD3
|
A:LYS833
|
4.0
|
0.3
|
1.0
|
HG3
|
A:LYS833
|
4.0
|
1.0
|
1.0
|
HD12
|
A:ILE879
|
4.0
|
97.4
|
1.0
|
HG22
|
A:ILE831
|
4.0
|
0.1
|
1.0
|
CG
|
A:LYS833
|
4.1
|
0.8
|
1.0
|
CD1
|
A:ILE879
|
4.1
|
97.3
|
1.0
|
CG
|
A:PRO810
|
4.3
|
0.4
|
1.0
|
C9
|
A:V811101
|
4.3
|
65.8
|
1.0
|
CB
|
A:LYS833
|
4.3
|
0.2
|
1.0
|
HZ3
|
A:LYS833
|
4.4
|
0.4
|
1.0
|
CB
|
A:PRO810
|
4.4
|
1.0
|
1.0
|
HZ2
|
A:LYS833
|
4.4
|
0.8
|
1.0
|
N11
|
A:V811101
|
4.5
|
67.6
|
1.0
|
HG21
|
A:ILE831
|
4.6
|
100.0
|
1.0
|
HB2
|
A:PRO810
|
4.6
|
0.1
|
1.0
|
H12
|
A:V811101
|
4.7
|
79.2
|
1.0
|
HE2
|
A:LYS833
|
4.7
|
0.8
|
1.0
|
C7
|
A:V811101
|
4.7
|
70.6
|
1.0
|
HG2
|
A:PRO810
|
4.7
|
0.0
|
1.0
|
CG2
|
A:ILE831
|
4.7
|
0.6
|
1.0
|
HA
|
A:LYS833
|
4.8
|
0.2
|
1.0
|
HB3
|
A:LYS833
|
5.0
|
0.1
|
1.0
|
|
Fluorine binding site 3 out
of 3 in 6xrm
Go back to
Fluorine Binding Sites List in 6xrm
Fluorine binding site 3 out
of 3 in the Crystal Structure of Human PI3K-Gamma in Complex with Compound 4
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Crystal Structure of Human PI3K-Gamma in Complex with Compound 4 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1101
b:76.1
occ:1.00
|
F4
|
A:V811101
|
0.0
|
76.1
|
1.0
|
C2
|
A:V811101
|
1.4
|
70.7
|
1.0
|
F3
|
A:V811101
|
2.2
|
71.9
|
1.0
|
F1
|
A:V811101
|
2.3
|
73.1
|
1.0
|
H2
|
A:V811101
|
2.4
|
70.4
|
1.0
|
C5
|
A:V811101
|
2.5
|
68.6
|
1.0
|
HG3
|
A:PRO810
|
2.7
|
0.0
|
1.0
|
C6
|
A:V811101
|
2.8
|
70.4
|
1.0
|
HG22
|
A:ILE831
|
3.2
|
0.1
|
1.0
|
CG
|
A:PRO810
|
3.5
|
0.4
|
1.0
|
HG2
|
A:PRO810
|
3.5
|
0.0
|
1.0
|
HD13
|
A:ILE831
|
3.7
|
0.1
|
1.0
|
C20
|
A:V811101
|
3.8
|
66.6
|
1.0
|
CG2
|
A:ILE831
|
4.1
|
0.6
|
1.0
|
HB2
|
A:PRO810
|
4.1
|
0.1
|
1.0
|
HB3
|
A:PRO810
|
4.1
|
0.1
|
1.0
|
CB
|
A:PRO810
|
4.1
|
1.0
|
1.0
|
C7
|
A:V811101
|
4.2
|
70.6
|
1.0
|
SD
|
A:MET804
|
4.2
|
0.8
|
1.0
|
HD11
|
A:ILE963
|
4.3
|
0.5
|
1.0
|
HG21
|
A:ILE831
|
4.3
|
100.0
|
1.0
|
HD11
|
A:ILE831
|
4.3
|
97.3
|
1.0
|
HG23
|
A:ILE831
|
4.4
|
0.8
|
1.0
|
CD1
|
A:ILE831
|
4.4
|
0.2
|
1.0
|
O19
|
A:V811101
|
4.6
|
68.2
|
1.0
|
HD2
|
A:LYS833
|
4.6
|
0.8
|
1.0
|
C18
|
A:V811101
|
4.7
|
68.2
|
1.0
|
H21
|
A:V811101
|
4.7
|
99.3
|
1.0
|
CD
|
A:PRO810
|
4.7
|
0.6
|
1.0
|
HD11
|
A:ILE879
|
4.7
|
99.6
|
1.0
|
HD3
|
A:PRO810
|
4.7
|
0.3
|
1.0
|
HE2
|
A:MET804
|
4.8
|
0.2
|
1.0
|
H18
|
A:V811101
|
4.8
|
97.0
|
1.0
|
C9
|
A:V811101
|
4.9
|
65.8
|
1.0
|
HD13
|
A:ILE879
|
4.9
|
96.8
|
1.0
|
HB
|
A:ILE963
|
5.0
|
0.7
|
1.0
|
N30
|
A:V811101
|
5.0
|
76.2
|
1.0
|
|
Reference:
S.L.Drew,
R.Thomas-Tran,
J.W.Beatty,
J.Fournier,
K.V.Lawson,
D.H.Miles,
G.Mata,
E.U.Sharif,
X.Yan,
A.K.Mailyan,
E.Ginn,
J.Chen,
K.Wong,
D.Soni,
P.Dhanota,
P.Y.Chen,
S.G.Shaqfeh,
C.Meleza,
A.T.Pham,
A.Chen,
X.Zhao,
J.Banuelos,
L.Jin,
U.Schindler,
M.J.Walters,
S.W.Young,
N.P.Walker,
M.R.Leleti,
J.P.Powers,
J.L.Jeffrey.
Discovery of Potent and Selective PI3K Gamma Inhibitors. J.Med.Chem. V. 63 11235 2020.
ISSN: ISSN 0022-2623
PubMed: 32865410
DOI: 10.1021/ACS.JMEDCHEM.0C01203
Page generated: Fri Aug 2 04:16:19 2024
|